Skip to main content

Table 4 Comparison of clinical parameters between groups

From: Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

Parameters

At admission

At discharge

statistical value

p

Group A: ALT (U/L)

35.05 ± 19.17

32.50 ± 24.72

1.571

0.116

Group B: ALT (U/L)

34.75 ± 22.93

31.13 ± 17.62

−1.220

0.222

statistical value

−0.454a

−0.220a

–

–

P

0.650

0.826

–

–

Group A: Cr (μmol/L)

68.50 ± 14.53

67.14 ± 1

−0.114

0.909

Group B: Cr (μmol/L)

75.26 ± 20.54

72.00 ± 13.63

−0.488

0.626

statistical value

−0.189a

−1.130a

–

–

P

0.276

0.183

–

–

Group A: CK (U/L)

49.68 ± 25.61

49.95 ± 15.35

−0.406

0.685

Group B: CK (U/L)

56.98 ± 32.40

55.51 ± 19.03

−0.887

0.375

statistical value

−0.361a

−1.030a

–

–

P

0.718

0.303

–

–

Group A:Hospitalization time (days)

27.41 ± 6.43

–

–

–

Group B:Hospitalization time (days)

30.07 ± 8.92

–

–

–

statistical value

1.246b

–

–

–

P

0.217

–

–

–

  1. a Wilcoxon rank-sum test. b Student’s t test